Publications by authors named "Thomas Brevig"

Claim this Profile
A
Advancing measurement-based care through triangle of care: Development and feasibility of the Transdiagnostic Global Impression - Psychopathology scale for patients and informants - ADDENDUM.
Roger S McIntyre, Zsofia Borbala Dombi, Agota Barabassy, Thomas Brevig, György Németh

Eur Psychiatry· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing measurement-based care through triangle of care: Development and feasibility of the Transdiagnostic Global Impression - Psychopathology scale for patients and informants.
Roger S McIntyre, Zsofia Borbala Dombi, Agota Barabassy, Thomas Brevig, György Németh

Eur Psychiatry· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transdiagnostic Efficacy of Cariprazine: A Systematic Review and Meta-Analysis of Efficacy Across Ten Symptom Domains.
Agota Barabassy, Réka Csehi, Zsófia Borbála Dombi, Balázs Szatmári, Thomas Brevig

Pharmaceuticals (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Transdiagnostic Global Impression - Psychopathology scale (TGI-P): Initial development of a novel transdiagnostic tool for assessing, tracking, and visualising psychiatric symptom severity in everyday practice.
Christoph U Correll, Zsófia B Dombi, Ágota Barabássy, György Németh, Thomas Brevig

Eur Neuropsychopharmacol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for migraine disease progression: a narrative review for a patient-centered approach.
Richard B Lipton, Dawn C Buse, Stephanie J Nahas, Gretchen E Tietjen, Vincent T Martin, Thomas Brevig

J Neurol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with eptinezumab for migraine prevention in people with chronic migraine and medication-overuse headache: a plain language summary.
Amaal J Starling, Melissa Kolbet, Roger Cady, Thomas Brevig

Pain Manag· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eptinezumab improved patient-reported outcomes in patients with migraine and medication-overuse headache: Subgroup analysis of the randomized PROMISE-2 trial.
Amaal J Starling, Robert P Cowan, Dawn C Buse, Hans-Christoph Diener, Michael J Marmura, Thomas Brevig

Headache· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 study.
Robert P Cowan, Michael J Marmura, Hans-Christoph Diener, Amaal J Starling, Jack Schim, Thomas Brevig

J Headache Pain· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient preference for early onset of efficacy of preventive migraine treatments.
Jessica Ailani, Paul Winner, Ann Hartry, Thomas Brevig, Martin Bøg

Headache· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes, health-related quality of life, and acute medication use in patients with a ≥ 75% response to eptinezumab: subgroup pooled analysis of the PROMISE trials.
Richard B Lipton, Larry Charleston, Cristina Tassorelli, Thomas Brevig, Joe Hirman

J Headache Pain· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early response to eptinezumab indicates high likelihood of continued response in patients with chronic migraine.
Dawn C Buse, Paul K Winner, Larry Charleston, Joe Hirman, Roger Cady, Thomas Brevig

J Headache Pain· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication-overuse headache.
Michael J Marmura, Hans-Christoph Diener, Robert P Cowan, Stewart J Tepper, Merle L Diamond, Thomas Brevig

Headache· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials.
Timothy R Smith, Egilius L H Spierings, Roger Cady, Joe Hirman, Barbara Schaeffler, Thomas Brevig

J Headache Pain· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials.
Timothy R Smith, Egilius L H Spierings, Roger Cady, Joe Hirman, Barbara Schaeffler, Thomas Brevig

J Headache Pain· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication-overuse headache: Subgroup analysis of PROMISE-2.
Hans-Christoph Diener, Michael J Marmura, Stewart J Tepper, Robert Cowan, Amaal J Starling, Thomas Brevig

Headache· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient characteristics, burden and pharmacotherapy of treatment-resistant schizophrenia: results from a survey of 204 US psychiatrists.
Christoph U Correll, Thomas Brevig, Cecilia Brain

BMC Psychiatry· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experiences, attitudes, and perceptions of caregivers of individuals with treatment-resistant schizophrenia: a qualitative study.
Cecilia Brain, Steven Kymes, Dana B DiBenedetti, Thomas Brevig, Dawn I Velligan

BMC Psychiatry· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-centered assessment of cognitive symptoms of depression.
Sheri E Fehnel, Barbara H Forsyth, Dana B DiBenedetti, Natalya Danchenko, Clément François, Thomas Brevig

CNS Spectr· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxygen reduces accumulation of type IV collagen in endothelial cell subcellular matrix via oxidative stress.
Thomas Brevig, Jette H Røhrmann, Holger Riemann

Artif Organs· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The recognition of adsorbed and denatured proteins of different topographies by beta2 integrins and effects on leukocyte adhesion and activation.
Thomas Brevig, Bjørn Holst, Zahida Ademovic, Noemi Rozlosnik, Jette H Røhrmann

Biomaterials· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activated porcine embryonic brain endothelial cells induce a proliferative human T-lymphocyte response.
Suchitra Sumitran-Holgersson, Thomas Brevig, Håkan Widner, Jan Holgersson

Cell Transplant· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydrodynamic guiding for addressing subsets of immobilized cells and molecules in microfluidic systems.
Thomas Brevig, Ulrich Krühne, Rachel A Kahn, Thomas Ahl, Michael Beyer

BMC Biotechnol· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Size-correlated division of labour and spatial distribution of workers in the driver ant, Dorylus molestus.
Christian Braendle, Neal Hockley, Thomas Brevig, Alexander W Shingleton, Laurent Keller

Naturwissenschaften· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipid-mediated glial cell line-derived neurotrophic factor gene transfer to cultured porcine ventral mesencephalic tissue.
Matthias Bauer, Morten Meyer, Thomas Brevig, Thomas Gasser, Hans Rudolf Widmer

Exp Neurol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis